Non-vitamin K antagonist oral anticoagulants vs. vitamin-K antagonists in patients with atrial fibrillation and chronic kidney disease: a nationwide cohort study

Non-vitamin K antagonist oral anticoagulants vs. vitamin-K antagonists in patients with atrial fibrillation and chronic kidney disease: a nationwide cohort study

Abstract Background We aimed to compare effectiveness and safety of non-vitamin K antagonist oral anticoagulants (NOACs) versus vitamin-K antagonists (VKA) in atrial fibrillation (AF) patients with chronic kidney disease (CKD) not receiving dialysis. Methods By using personal identification numbers,...

Full description

Bibliographic Details
Main Authors: Emma Kirstine Laugesen, Laila Staerk, Nicholas Carlson, Anne-Lise Kamper, Jonas Bjerring Olesen, Christian Torp-Pedersen, Gunnar Gislason, Anders Nissen Bonde
Format: Article
Language:English
Published: BMC 2019-11-01
Series:Thrombosis Journal
Subjects:
Atrial fibrillation
Chronic kidney disease
NOAC
VKA
Oral anticoagulation
Online Access:http://link.springer.com/article/10.1186/s12959-019-0211-y

Internet

http://link.springer.com/article/10.1186/s12959-019-0211-y

Similar Items